🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter study will determine the response rate, the complete respo...
Status
Completed
Location
Multiple Locations
Start Date
1998-04
Trial ID
NCT00938041
Treatments Being Tested
Thyroiditis includes inflammatory thyroid disorders such as Hashimoto's thy...
Status
Recruiting
Location
Mansoura University
Start Date
2026-06-15
Trial ID
NCT07571681
Treatments Being Tested
Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune dis...
Status
Recruiting
Location
Shanghai Changzheng Hospital
Start Date
2025-04-10
Trial ID
NCT07152340
Treatments Being Tested
This is a Phase 2 Study of Everolimus and Lenvatinib in patients with metas...
Status
Suspended
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2017-04-03
Trial ID
NCT03139747
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the combinati...
Status
Unknown
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2020-10-01
Trial ID
NCT04524884
Treatments Being Tested
Thyroid dysfunction following radioiodine for Graves' disease is common, po...
Status
Completed
Location
Newcastle upon Tyne Hospitals NHS Foundation Trust
Start Date
2013-03
Trial ID
NCT01885533
Vitiligo is an acquired pigmentary disorder on skin and/or mucosae, which i...
Status
Unknown
Location
Multiple Locations
Start Date
2024-02-24
Trial ID
NCT06261086
Treatments Being Tested
To identify in patients admitted for Voluntary drug poisoning (IMV) by psyc...
Status
Unknown
Location
University Hospital Toulouse
Start Date
2018-01-02
Trial ID
NCT03481192
Treatments Being Tested
At present, there are still few observational studies on Graves' disease in...
Status
Unknown
Location
Ruijin hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-10-01
Trial ID
NCT05043233
Treatments Being Tested
Phase 1 dose escalation will determine the first cycle dose-limiting toxici...
Status
Recruiting
Location
Local Institution - 2129
Start Date
2017-03-07
Trial ID
NCT03093116
Treatments Being Tested